Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation
Abstract Background The vision loss in Leber hereditary optic neuropathy patients is due to mitochondrial DNA mutations. No treatment has shown a clear-cut benefit on a clinically meaningful end-point. However, clinical evidences suggest two therapeutic approaches: the reduction of the mutation load...
Main Authors: | Sonia Emperador, Ester López-Gallardo, Carmen Hernández-Ainsa, Mouna Habbane, Julio Montoya, M. Pilar Bayona-Bafaluy, Eduardo Ruiz-Pesini |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-019-1128-z |
Similar Items
-
Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
by: Angelica Bianco, et al.
Published: (2018-12-01) -
Increased protein S-glutathionylation in Leber’s hereditary optic neuropathy (LHON)
by: Zhou, Lei, et al.
Published: (2021) -
La neuropatia ottica ereditaria di Leber (Leber Hereditary Optic Neuropathy, LHON)
by: Maria Lucia Cascavilla
Published: (2017-02-01) -
Leber’s Hereditary Optic Neuropathy (LHON): Clinical Experience and Outcomes after Long-Term Idebenone Treatment
by: George Baltă, et al.
Published: (2023-09-01) -
Phenotypic Variation of Autosomal Recessive Leber Hereditary Optic Neuropathy (arLHON) in One Family
by: Dorota Pojda-Wilczek, et al.
Published: (2022-11-01)